최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기European neurology, v.79 no.3/4, 2018년, pp.214 - 220
Min, Seung Nam (Department of Fire Safety Management, Shinsung University, Dangjin, Republic of Korea) , Park, Se Jin (Korea Research Institute of Standards and Science (KRISS) and Electronics and Telecommunications Research Institute (ETRI), Daejeon, Republic of Korea) , Kim, Dong Joon (Department of Industrial and Management Engineering, Hanyang University, Ansan, Republic of Korea) , Subramaniyam, Murali (Department of Mechanical Engineering, SRM Institute of Science and Technology, Kattankulathur, India) , Lee, Kyung-Sun (Department of Industrial Safety Management, Suncheon Jeil College, Suncheon, Republic of Korea)
AbstractBackground: Stroke is the second leading cause of death worldwide and remains an important health burden both for the individuals and for the national healthcare systems. Potentially modifiable risk factors for stroke include hypertension, cardiac disease, diabetes, and dysregulation of gluc...
1. Hong KS, Bang OY, Kang DW, Yu KH, Bae HJ, Lee JS, Heo JH, Kwon SU, Oh CW, Lee BC, Kim JS, Yoon BW: Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the Korean stroke society and clinical research center for stroke. J Stroke 2013; 15: 2-20. 24324935 10.5853/jos.2013.15.1.2
2. Oh CM, Won YJ, Jung KW, et al: Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 2016; 48: 436-450. 26987395 10.4143/crt.2016.089
3. Clinical Research Center for Stroke. Clinical Practice Guidelines for Stroke, ed 3. Korea, 2015.
4. Organization for Economic Co-operation and Development: OECD Reviews of Health Care Quality OECD Reviews of Health Care Quality: Korea 2012: Raising Standards; In: OECD Reviews of Health Care Quality. Paris, OECD Publish Inger, 2012, p 146.
5. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, Beasley TM, Martin-Schild S: Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis 2013; 22:e207-e213. 23246190 10.1016/j.jstrokecerebrovasdis.2012.11.006
6. Brown RD, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO: Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996; 27: 373-380. 8610298
7. Wolf PA, D’agostino RB, O’neal MA, Sytkowski P, Kase CS, Belanger AJ, Kannel WB: Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992; 23: 1551-1555. 1440701 10.1161/01.STR.23.11.1551
8. Association AH: Heart Disease and Stroke Statistics-2004 Update. American Heart Association. Dallas, TX, 2003.
9. Lawlor DA, Ronalds G, Clark H, Smith GD, Leon DA: Birth weight is inversely associated with incident coronary heart disease and stroke among individuals born in the 1950s: findings from the Aberdeen Children of the 1950s prospective cohort study. Circulation 2005; 112: 1414-1418. 16129799 10.1161/CIRCULATIONAHA.104.528356
10. Lewington S: Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2003; 360: 1903-1913. 12493255 10.1016/S0140-6736(02)11911-8
11. Psaty BM, Lumley T, Furberg CD: Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544. 12759325 10.1001/jama.289.19.2534
12. Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-794. 2496858 10.1136/bmj.298.6676.789
13. Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R: Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control 1999; 8: 156-160. 10478399
14. You RX, Thrift AG, McNeil JJ, Davis SM, Donnan GA: Ischemic stroke risk and passive exposure to spouses’ cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. Am J Public Health Res 1999; 89: 572-575. 10191806 10.2105/AJPH.89.4.572
15. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988. 1866765 10.1161/01.STR.22.8.983
16. Goldstein LB, Adams R, Alberts MJ, et al: Primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council: Cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group: the American academy of neurology affirms the value of this guideline. Stroke 2006; 37: 1583-1633. 16675728 10.1161/01.STR.0000223048.70103.F1
17. Stratton IM, Adler AI, Neil HA, et al: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412. 10938048
18. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696. 15325833 10.1016/S0140-6736(04)16895-5
19. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE: Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003; 290: 2685-2692. 14645310 10.1001/jama.290.20.2685
20. van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B: Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002; 288: 2441-2448. 12435257 10.1001/jama.288.19.2441
21. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501. 10507957 10.7326/0003-4819-131-7-199910050-00003
22. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870. 11401607 10.1001/jama.285.22.2864
23. Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P: Selecting patients with atrial fibrillation for anticoagulation. Circulation 2004; 110: 2287-2292. 15477396 10.1161/01.CIR.0000145172.55640.93
24. Mohr J, Grotta JC, Wolf PA, Moskowitz MA, Mayberg MR, Von Kummer R: Stroke E-Book: Pathophysiology, Diagnosis, and Management: Elsevier Health Sciences, 2011.
25. Amarenco P, Labreuche J, Lavallée P, Touboul PJ: Statins in stroke prevention and carotid atherosclerosis. Stroke 2004; 35: 2902-2909. 15514180 10.1161/01.STR.0000147965.52712.fa
26. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57. 12090862 10.1001/jama.288.1.49
27. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-233. 12117397 10.1001/jama.288.3.321
28. Song YM, Sung J, Davey Smith G, Ebrahim S: Body mass index and ischemic and hemorrhagic stroke. Stroke 2004; 35: 831-836. 15001798 10.1161/01.STR.0000119386.22691.1C
29. Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, Buring JE, Manson JE: Body mass index and the risk of stroke in men. Arch Intern Med 2002; 162: 2557-2562. 12456227 10.1001/archinte.162.22.2557
30. Folsom AR, Prineas RJ, Kaye SA, Munger RG: Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke 1990; 21: 701-706. 2339449 10.1161/01.STR.21.5.701
31. Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Pail MC: Abdominal obesity and risk of ischemic stroke. Stroke 2003; 34: 1586-1592. 12775882 10.1161/01.STR.0000075294.98582.2F
32. Cho NH, Kim KM, Choi SH, Park KS, Jang HC, Kim SS, Sattar N, Lim S: High blood pressure and its association with incident diabetes over 10 years in the Korean Genome and Epidemiology Study (KoGES). Diabetes Care 2015; 38: 1333-1338. 25986660 10.2337/dc14-1931
33. Lee HY, Park JB: The Korean Society of Hypertension Guidelines for the management of hypertension in 2013: its essentials and key points. Pulse 2015; 3: 21-28. 26587454 10.1159/000381994
34. Korean Diabetes Association (KDA): Treatment guideline for diabetes. J Korean Diabetes 2011; 12:S1-S244.
35. Korean Academy of Medical Sciences (KAoM): Evidence-based Recommendations for Dyslipidemia in Primary Care. Korea, 2017.
36. Park JH, Jo MS: NCEP (National Cholesterol Education Program) expert panel on detection, evaluation, and treatement of high blood cholesterol in adults (ATP III). Korean J Lipidol 2001; 11: 420-429.
37. Salihu HM, Bonnema SM, Alio AP: Obesity: what is an elderly population growing into? Maturitas 2009; 63: 7-12. 19328637 10.1016/j.maturitas.2009.02.010
38. Han NY, Ko EA, Hwang SY: Knowledge of stroke symptoms and risk factors among older adults. Korean J Adult Nurs 2009; 21: 314-323.
39. Park TH, Kim MK, Lee KB, Park JM, Lee SJ, Jung KH, Cho YJ, Lee JS, Lee j, Bae HJ: Prevalence of risk factors for ischemic stroke in Korean: a systematic review. J Korean Neurol Assoc 2009; 27: 19-27.
40. Mackay J, Mensah GA, Mendis S, Greenlund K: The Atlas of Heart Disease and Stroke. World Health Organization, 2004.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.